Insugen 30/70 Injection 100IU/ml (Insulin Isophane/NPH (70%) + Human Insulin/Soluble Insulin (30%)

Insugen 30/70 Injection 100IU/ml is a combination of two medicines, an intermediate-acting and a short-acting type of insulin. It is used in the treatment of diabetes mellitus (type 1 and 2) to improve blood sugar control both in adults and children. It helps maintain the blood sugar levels in diabetic patients.

Insugen 30/70 Injection 100IU/ml is normally prescribed along with other diabetes medicines. Your doctor or nurse will teach you the correct way of injecting it under the skin. It should be taken 15 minutes before a meal or within 20 minutes after starting a meal. Don’t stop taking it unless your doctor tells you to.

It is only part of a treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by your doctor. Check your blood sugar levels regularly, keep track of your results and share them with your doctor. This is very important to work out the correct dose of the medicine for you.

The most common side effect of this medicine is low blood sugar levels (hypoglycemia). To prevent this, it’s important to always inject the correct dose of medicine only, have regular meals, and monitor your blood sugar levels regularly. Drinking excessive alcohol can also lead to a fall in your blood sugar levels. Other side effects include reactions at the injection site like redness or swelling. Some people gain weight while taking insulin.  You may also notice a rash, edema (swelling), or itching while taking this medicine.

Do not use this medicine when you have low blood glucose levels (hypoglycemia). Tell your doctor if you’ve ever had kidney, liver or heart problems before starting treatment. Pregnant or breastfeeding women should also consult their doctor as the dose may need to be changed.

“Harmonizing Blood Sugar: The Dynamic Blend of Insulin Isophane/NPH (70%) + Human Insulin/Soluble Insulin (30%)”

In the intricate choreography of diabetes management, the combination of Insulin Isophane/NPH (70%) and Human Insulin/Soluble Insulin (30%) emerges as a symphony of precision. This unique blend brings together the sustained action of NPH insulin with the rapid response of soluble insulin, creating a harmonious and versatile approach to glycemic control. The 70/30 ratio reflects a strategic formulation, offering a balanced solution to address both baseline insulin needs and immediate postprandial spikes. By mimicking the natural insulin release patterns, this dynamic combination provides individuals with diabetes a more tailored and effective strategy to navigate the complexities of blood sugar management.

 “Precision in a Vial: Unraveling the Nuances of Insulin Isophane/NPH 70% + Human Insulin/Soluble Insulin 30%”

Delving into the intricacies of insulin therapy, the combination of Insulin Isophane/NPH (70%) + Human Insulin/Soluble Insulin (30%) exemplifies precision encapsulated in a vial. This unique formulation offers a nuanced response to the multifaceted needs of individuals with diabetes. The 70/30 ratio signifies a careful calibration, providing a tool for healthcare providers to tailor insulin therapy to the specific requirements of each patient. From maintaining a steady baseline to swiftly addressing postprandial glucose fluctuations, this insulin blend stands as a testament to precision in diabetes care. This blog unravels the subtle complexities of Insulin Isophane/NPH 70% + Human Insulin/Soluble Insulin 30%, showcasing its role in offering a more precise and personalized approach to blood sugar modulation.